← FDA Drug Approvals (Drugs@FDA)

IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 2024-11-08

Drug application

FDA Application #
ANDA214789
Application type
Abbreviated New Drug Application (Generic)
Brand name
IBUPROFEN
Generic name
IBUPROFEN
Active ingredients
IBUPROFEN
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Over-the-counter
Sponsor
PAI HOLDINGS PHARM
Manufacturer
PAI Holdings, LLC dba PAI Pharma
First approval
2024-11-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown